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Abstract
The progress in nanotechnology and the medical application of novel generations of
nanomaterials  have  opened  new  horizons  in  the  definition  of  non-conventional
approaches against multiple diseases. Biomaterials coated with antimicrobial metal
nanoparticles,  along  with  the  topical  applications  of  zinc,  silver  or  copper-based
formulations  have  demonstrated  huge  potential  in  prevention  from  infections
associated with implantable medical  devices and in biofilm eradication.  In wound
healing,  in  particular,  the  increasing  healthcare  costs  and  the  antibiotic  resistance
demonstrated by several microorganisms have encouraged researchers and companies
in the development of innovative wound dressings with antibacterial properties and
capability  to  promote  and  enhance  the  healing  process.  Supported  by  scientific
evidence, many formulations have been proposed and a large number of works involves
the use of hybrid metal nanoparticles/polymer products, which have demonstrated
encouraging results both in vitro and in vivo. In this chapter, recent progress in the
development of novel wound dressings based on antibacterial metal nanoparticles is
presented, along with the most interesting results achieved by the authors, mainly
devoted to the application of silver nanocoatings in wound management.
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1. Introduction
The Wound Healing Society has defined the wound as the result of ‘disruption of normal
anatomic structure and function’. A wound can be also described as a defect or break in the
skin, which results from physical or thermal damage, or from medical and physiological
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conditions [1]. The wound healing is a dynamic process consisting of four continuous and
precisely programmed phases, namely haemostasis, inflammation, proliferation and remod-
elling. Multiple factors, such as infections, stress, diabetes, smoking and obesity, can lead to
impaired wound healing by interfering with one or more of these phases [2]. Once injured,
the skin loses many of the protective defence mechanism of the intact skin and is colonized
by the microorganisms on its surface. According to the replication status of the microorgan-
isms, a wound can be classified as contaminated, colonized, locally infected and/or with
spreading invasive infection [3]. The main bacterial mode of living in an infected wound is
biofilm, which can be defined as a confluent community of adherent bacteria characterized by
high cell densities and encased in an extracellular polymeric matrix that acts as physical barrier
for biological and pharmaceutical antimicrobials [4, 5]. The presence of bacterial biofilm is
associated with impaired epithelialization and granulation tissue formation and promotes a
low-grade inflammatory response that interferes with wound healing [6]. The biofilm matrix
plays an important role in the increased antibiotic resistance and has an enormous impact on
medicine in terms of both therapeutic options and costs. Biofilm has been estimated to be
associated with 65% of nosocomial infections, and the treatment costs associated with biofilm
infection and chronic wounds have been estimated to be more than 1 billion USD annually in
the United States [4, 7].
The increasing resistance of bacteria to antibiotics represents a huge concern, so that the World
Health Organization recently has described the problem as ‘so serious that it threatens the
achievements of modern medicine’ [8, 9]. Moreover, the large number of wound dressings and
the limited guidelines available have induced an undesirable inconsistency in wound-care
practice [10]. The local treatment of wounds is crucial for preventing infections, controlling
exudates and providing the moist environment necessary for wound healing. At this purpose,
efforts have been made by many research groups in the development of bioactive dressings,
which can play an active role in wound protection and healing, and/or are able to release
biomolecules and antimicrobials for prevention and treatment of wound infections [8, 11, 12].
A strategy for the treatment of infected wounds with increased resistance to traditional
antibiotic therapy is the use of specific antibacterial agents immobilized on the surface of a
material, thus providing a wide spectrum of activity in terms of bacterial toxicity and destruc-
turation of the bacterial biofilm matrix [13].
This chapter aims to provide the reader with an overview of the most promising routes to
develop advanced biomaterials with antimicrobial properties for the management of wound
infections through nanotechnology approaches. The new generation and application of
nanomaterials with novel properties are one of the century’s key technology developments,
which offer extraordinary opportunities in the pharmaceutical and medical field [14]. The great
potential of nanometals such as zinc, copper and silver in wound dressing formulations and
their use as antimicrobial agent in wound infections will be presented, along with the most
recent efforts and results achieved by several research group in the definition of effective
strategies for prevention of wound infection and for enhanced wound healing. Moreover, the
most relevant results obtained by the authors of this chapter in the field of silver-based
antibacterial treatments for wound-healing application will be presented and discussed.
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2. Wound infections
The skin represents a complex and effective barrier between the organism and the environ-
ment, preventing invasion of pathogens, chemical and physical insults and unregulated loss
of water and solutes [15]. From a microbiological point of view, the primary function of nor-
mal and intact skin is to control the microbial populations that live on the skin surface and
to prevent the underlying tissues from invasion and colonization by potential pathogens
[16]. A wound, which represents the loss of skin integrity and following exposure of subcu-
taneous tissue, provides a moist, warm and nutritious environment for microbial coloniza-
tion and proliferation. The abundance and diversity of microorganisms in any wound
depend on different factors such as wound type, depth, location and quality, the level of
tissue perfusion and the antimicrobial efficacy of the host immune response [16]. As all open
wounds lack the protective covering of skin, microorganisms from endogenous or exoge-
nous sources can be introduced onto the wound surface and can lead to colonization [17,
18]. Colonization is defined as the presence of proliferating bacteria on the surface of a
wound, without a noticeable host response and without clinical signs and symptoms. Differ-
ently, wound infection depends on the pathogenicity of the microorganisms and on the im-
mune competency of the host, and it is characterized by the presence of the clinical signs of
infection such as erythema, pain, tenderness, heat, oedema, cellulites and abscess or pus [19,
20]. Within an infected wound, the main bacterial mode of living is a biofilm [4]. Bacterial
biofilm consists of a complex microenvironment of single or mixed bacterial species encased
within an extracellular polymeric substance (EPS) produced by bacteria. The moist, adhe-
sive and proteinaceous wound surface represents the ideal environment for biofilm devel-
opment [21]. If microbes attach to the wound surface and proliferate, the biofilm begins to
develop and, when it is well established, it exhibits resistance to the host immune system
and antimicrobials. At this stage, the biofilm is considered mature and difficult to eradicate,
thus requiring specialized management practices and increasing the risk of non-healing and
clinically infected wound (i.e. showing signs of inflammation or purulence) [17]. Biofilm in-
fections compromise wound closure and contribute to wound chronicity. Persistent infec-
tions may arrest the growth of the repairing tissue and significantly [22] impairing the key
healing processes such as the inflammatory immune response, granulation tissue formation
and epithelialization. Although a moist environment is necessary for optimal wound heal-
ing, poor moisture/exudate control within a wound environment promotes the develop-
ment of biofilm. Consequently, moisture balance is essential to optimize the wound
environment for healing and minimize the opportunity for biofilms to develop [23–25]. Pre-
venting biofilm is fundamental for faster and more effective treatment of chronic wounds
[17]. However, despite the evidence for the presence of biofilm in wounds, research studies
are required to detect biofilm and to determine the exact role played by multispecies bio-
films in terms of delayed wound-healing process [26]. Different biofilms can be identified
within a wound environment, such as aggregates of cells dispersed within the wound exu-
date, in slough or on necrotic tissue or on the wound dressing [27]. The microbial communi-
ty presents multiple difficulties for clinicians in attempting to heal a chronic wound.
Biofilms are resistant to many biocides, antibiotics and wound-care products. So, managing
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biofilm often involves its physical removal from the wound surface with sharp or surgical
debridement [28].
The control of biofilm is a key part of chronic wound management, but the use of antiseptic
dressings for preventing and managing biofilm and infection still needs further research
involving well-designed, randomized controlled trials [29]. The concept of a bacterial contam-
ination, colonization and biofilm-related infection is now widely accepted in wound care, and
the recognition of the biofilm and the evolution of topical antiseptics to control bioburden in
wounds are considered strictly related to the concept of TIME (tissue, infection/inflammation,
moisture balance and edge of wound) and to its relation with the current best practice [30]. In
healthcare, infections lead to longer hospital stays for patients, specifically wound dressings
and increased hospital costs [12]. Also worsened by an ageing population and the incidence
of diabetes and obesity, the huge economic and social impact of wounds requires higher level
of attention and resources to understand biological mechanisms underlying cutaneous wound
complications [31].
Infections of the dermis, including burns, surgical site infections and non-healing diabetic foot
ulcers affect over a million people. Individuals with diabetes represent a particularly vulner-
able category because many of them develop foot ulceration during the course of their disease
and undergo amputation. In addition to diabetics, several other groups of immune-compro-
mised patient populations are plagued by slow-healing and non-healing wounds, such as
trauma and burn victims, cancer patients and pressure ulcers in the elderly [32]. The incidence,
morbidity, mortality and costs associated with non-healing of chronic skin wounds are
dramatic. Chronic wounds cost millions of dollars annually in the healthcare industry of the
United States, and biofilm significantly contributes many billions of dollars to the global cost
of chronic wounds because of its role in delaying the wound-healing process and extending
the inflammatory phase of repair [19, 33–35].
Along with the direct medical costs borne by the hospital or insurer, also indirect costs in-
cluding lost patient productivity and diminished functional status should be considered
[36]. The control of bioburden is recognized as an important aspect of wound management,
which requires new solutions against microbes and their biofilms. Octenidine dihydrochlor-
ide and polyhexanide are effective and tolerated antiseptics used in wound management
today, but antiseptics alone may not be able to achieve wound healing without addressing
other factors such as the general health of patients or the wound’s physical environment [37,
38]. Next generation of wound treatment strategies for non-healing chronic wounds can be
achieved by adopting a biofilm-based management approach to wound care, in order to kill
and prevent reattachment of microorganisms [26].
3. The antibacterial activities of metals
The antibiotic resistance of microorganisms determines serious complications like infection,
and delayed wound healing and great concerns are related to the numbers and types of
residing microorganisms and the ability of the host’s immune system to control their prolif-
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eration [39–41]. Along with the emergence of microorganisms’ resistance to multiple antibi-
otics, the increased healthcare costs and the huge social and economic impact of wound care
have increased attention towards the biological mechanisms underlying cutaneous wound
complications and have encouraged the researchers towards the development of new bacter-
icide agents [31, 42]. The new frontier in clinical medicine and disease burden is represented
by the medical applications of nanotechnology. Antimicrobial nanoparticles (NPs) offer an
effective approach against numerous microorganisms where conventional antimicrobial
agents fail [43, 44] and, compared with micron-sized particulate matter, have greater potential
to enter cells and be more biologically active due to their small size and large surface area [X3].
Endowing ordinary products with new functionalities, consumer products containing
engineered nanoparticles, are growing tremendously, and the global nanotechnology industry
is becoming a major economic force of the twenty-first century [45, 46]. Some natural antibac-
terial materials such as zinc, silver and copper possess great antibacterial properties at
nanometric size and their way of interaction with bacteria provides unique bactericidal
mechanisms [43, 47].
Zinc is a transitional metal known since ancient time and widely distributed in the human
environment. Today, many zinc-containing products are available for topical application in
wound management due to the demonstrated improved re-epithelialization, reduced
inflammation and bacterial growth. [48, 49]. ZnO has demonstrated to possess both antibac-
terial and anti-inflammatory properties and to accelerate the healing of both acute and chronic
wounds. ZnO-NPs have exhibited antimicrobial capability and effectiveness against Gram-
positive and Gram-negative bacteria, including pathogens such as Escherichia coli, Salmonella,
Listeria monocytogenes and Staphylococcus aureus [49]. Several mechanisms have been reported
for the antibacterial activity of ZnO-NPs. Some of them involve the interaction with membrane
lipids and structure, leading to loss of membrane integrity, malfunction, and finally to bacterial
death. ZnO-NPs may also penetrate into bacterial cells, thus resulting in the production of
toxic oxygen radicals, which damage DNA, cell membranes or cell proteins [50–52]. The direct
interaction between ZnO nanoparticles and cell surfaces affects the permeability of membranes
and results in the inhibition of cell growth and cell death. Recent studies have also shown that
these nanoparticles have selective toxicity to bacteria but exhibit minimal effects on human
cells, thus suggesting their potential as nanomedicine-based antimicrobial agents [53, 54].
The bactericidal effect of metal nanoparticles has been attributed to their small size and high
surface to volume ratio, and it is not merely due to the release of metal ions in solutions [55].
Copper ions released subsequently may bind with bacterial DNA molecules and disrupt
biochemical processes inside bacterial cells. The exact mechanism behind bactericidal effect of
copper nanoparticles is not fully elucidated; however, Cu-NPs were found to cause multiple
toxic effects such as generation of reactive oxygen species, lipid peroxidation, protein oxidation
and DNA degradation in E. coli [47, 56]. Although the potential use of copper-based nanoma-
terials in wound healing has recently emerged and also supported by the hypothesis that
copper ions regulate the activity and expression of proteins involved in the wound repair
process, however, the synthesis of stable metallic Cu-NPs still remains a challenge because of
the rapid oxidation to Cu2+ ions in air or aqueous media [47, 57].
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In combination with silver, copper nanoparticles may give rise to more complete bactericidal
effect against a mixed bacterial population [56]. The broad-spectrum antimicrobial activity of
silver has been demonstrated against a wide range of microorganisms, including methicillin
resistant bacteria, fungi and viruses [58]. Although the exact antimicrobial mechanism still
represents a debated topic, many theories on the action of silver nanoparticles on microbes
have been proposed. One of them involves the anchorage and penetration of the nanoparticles
into the bacterial cell wall, which cause structural changes in the cell membrane such as
permeability and respiration [59–62]. E. coli cells treated with silver nanoparticles appear
damaged and show the formation of ‘pits’ in the cell wall of the bacteria, where the silver
nanoparticles accumulate [59, 63]. Another antibacterial mechanism involves the release of
silver ions and their interaction with the enzymes of the respiratory chain, the cell membrane
and the DNA. The binding of silver to the membrane can inhibit the passage of nutrients
through the membrane, interfering with normal concentration gradients between the cell and
the surrounding environment, so leading to cell death [64, 65]. The formation of free radicals
has also the ability to damage the cell membrane and makes it porous, thus causing the death
of bacteria [66].
Nanosilver products safety data available in EPA’s formal incident reporting database indicates
that nanosilver products are safe. Silver nanoparticles can be easily incorporated into matrix
materials and have demonstrated a great potential in applications of huge interest in nano-
technology [66]. When incorporated into wound treatment systems, silver nanoparticles can
provide clinically relevance in the development of ideal environment for rapid and effective
healing. These systems may significantly reduce the time required for the homeostatic
equilibrium, while reducing the risk of complications and improving the physical appearance
of the scar [67]. Silver nanoparticles induce rapid healing and improved cosmetic appearance
in a dose-dependent manner and exert positive effects through their antimicrobial properties,
reduction in wound inflammation and modulation of fibrogenic cytokines [68].
4. Metal nanoantimicrobials for wound dressing applications
Wound healing still represents a clinical challenge, which requires efficient wound manage-
ment strategies [69]. Indeed, a crucial component of wound care is the choice of dressing. Many
modern wound dressings have been developed to promote wound healing, such as dressings
designed to absorb exudate, to provide an ideal moisture balance at the wound surface, to
prevent maceration of surrounding tissue and infections and to reduce the bacterial load [70,
71]. Biomaterials, such as chitosan, alginate and collagen, play an important role as wound
dressing materials by accelerating the healing of wounds and also because they can embed
many nanoparticles for the development of metal nanoparticles-based wound dressings [69,
72]. Hydrogel-based wound dressings provide a cooling sensation and a moisture environ-
ment [73]. Several systems based on the combination of hydrogel and metal nanoparticles,
such as zinc, copper and silver, have been recently proposed by many authors, aiming to
develop wound dressings with antibacterial and enhanced wound-healing properties. For
example, an alginate hydrogel/zinc oxide nanoparticles composite bandage was developed
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by Mohandas et al. using a freeze-drying method. The results obtained demonstrated control-
led degradation profile and faster blood clotting ability, along with excellent antimicrobial
activity against different microorganisms such as Escherichia coli, Staphylococcus aureus, Candida
albicans and methicillin resistant S. aureus (MRSA) [74]. β-chitin hydrogel/nZnO composite
bandages with interconnected micro-porous structure were also obtained by freeze-drying
technique and proposed for infected wounds with large volume of exudate. Indeed, the
wounds treated with the composite bandages promoted the healing and the re-epithelializa-
tion, enhanced collagen deposition and showed reduced number of bacterial colonies [75].
Other formulations involving the use of chitin hydrogel/nano ZnO composite bandages were
proposed by Kumar et al. for burn, diabetic and chronic wound defects, because of the
enhanced swelling, blood clotting and antibacterial properties achieved [76]. Kumar et al. have
also developed a flexible and microporous chitosan hydrogel/nano zinc oxide composite
bandages by incorporating the zinc oxide nanoparticles into chitosan hydrogel. In vivo wound-
healing evaluations proved the enhanced healing ability of the materials without causing
toxicity to cells [73]. Chitosan and copper nanoparticles co-introduced into an ointment
preparation were investigated by Rakhmetova et al. and their combination at certain ratio of
components, concentrations and physicochemical characteristics enhanced the antibacterial
and wound-healing properties of the individual components [77]. Babushkina et al. demon-
strated the efficacy of local application of a suspension of copper and zinc nanoparticles and
of a drug based on chitosan and copper/zinc on bacterial contaminated purulent wound in
rats [78]. Copper (II) cross-linked alginate hydrogels with body fluid absorption ability and
haemostatic properties were developed and suggested by Klinkajon and Supaphol for the
treatment of exudation/bleeding wounds and burns [79].
Among the recent trends against burn infections involving the use of noble metal antimicro-
bials, the most prevalent is represented by silver [80]. For nearly 50 years, silver-containing
compounds have been the mainstay of burn wound care and silver sulfadiazine (SSD) has been
the standard topical antimicrobial for burn wounds for decades [64, 81].
Silver has been used as an antimicrobial agent for a long time in the form of metal silver and
silver sulfadiazine ointments [41], and today, there is scientific evidence supporting the use of
silver-based wound dressings highlighting antimicrobial efficacy on biofilms within the in vitro
and in vivo environments [40]. A number of wound dressings developed using silver have been
approved by the US Food and Drug Administration (FDA) [82]. In addition to antimicrobial
activity, silver dressings may modulate or reduce wound pain and limit the frequency of
changes [83]. While topical silver creams and solutions require frequent application, the
dressings can control the release of silver to the wound and require to be changed with less
frequency [84]. Nanocrystalline silver dressings are considered as the gold standard in the
conservative treatment of wounds and burns. It has been demonstrated that nanosilver has
both anti-inflammatory effects and improves wound healing [85]. The healing response
studied by Chowdhury et al. in laparotomy wounds after application of silver nanoparticles
determined increased collagen expression from dermal fibroblasts, improved wound healing
and reduced microbial load [86]. Rigo et al. have observed that the application of Ag NP-based
dressing for prolonged time does not affect the proliferation of fibroblasts and keratinocytes,
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leading to the restoration of the organized skin structure in previously unhealed parts of the
wound [87]. Polyvinyl alcohol (PVA) hydrogels loaded with a controlled concentration of silver
could combine the hydrogel property of keeping a moisturized environment, thus stimulating
healing, with the effect of silver of inhibiting or killing the bacteria [88]. PVA-Ag NPs mats,
fabricated by Nguyen et al. from a suspension of PVA and Ag NPs after microwave irradiation,
possess high tensile stress and anti-bacterial activities at the same time and were proposed as
a promoter of wound healing [89].
Hydrogels with polyvinyl pyrrolidone (PVP) and alginate were synthesized by Singh et al.,
and silver nanoparticles were incorporated in hydrogel network using gamma radiation. The
hydrogel-containing nanosilver demonstrated strong antimicrobial effect and complete
inhibition of microbial growth, absorption capacity, moisture permeability and the ability to
prevent fluid accumulation in exudating wound [90]. Chitosan-PVP-nanosilver oxide wound
dressings showed excellent results such as good swelling capability, good antibacterial activity
and also transparency of the film, which helps to regularly monitor the condition of wound
without removing it from the wound site [81]. The silver nanocrystalline chitosan dressing
described by Lu et al. significantly increased the rate of wound healing and was associated
with silver levels in blood and tissues well below those associated with the silver sulfadiazine
dressing (p < 0.01) [91]. Silver released in a moist wound surface environment significantly
increases the rate of re-epithelialization compared to a standard antibiotic solution, as
demonstrated by Demling et al. [92].
The application of both silver dressings and antibiotic therapy can have a synergistic effect in
improving wound healing, since the interaction of silver released from the dressings signifi-
cantly increases the susceptibility of bacterial cells within biofilms to antibiotics. Moreover, the
reduction of the silver particle size to nanoscale level provides better penetration and accu-
mulation of silver within biofilms, thus contributing to the effectiveness of the silver based
product [93]. As silver is the most widely used substance to obtain antimicrobial effects,
different formulations involving the use of silver-containing solution or silver nanoparticles
have been developed. Among the most widespread antimicrobial dressings, silver foam
dressings and silver alginate dressings are applied to exuding wounds and demonstrate
improved performances than the traditional gauze dressings [94]. Silver alginate wound
dressings have demonstrated beneficial effects on wound healing, in terms of wound exudates
levels and prevention from wound infections [95–97]. Silver alginate dressings are particularly
known for the prolonged antimicrobial efficacy, which indicates sustained availability of ionic
silver and suggests the necessity of reduced dressings changes [98]. Excellent and sustainable
controllability of Ag+ release were obtained by the AgNP-bacterial cellulose hybrid nanostruc-
ture developed by Wu et al., which offered promising results for antimicrobial wound dressing
through the addition of silver nanoparticles. Indeed, bacterial cellulose has attracted great
attention as novel wound dressing material, but it has no antimicrobial activity [99]. The silver
nanoparticle/bacterial cellulose gel membranes developed by Wu et al. demonstrated in vivo
excellent healing effects in a second-degree rat wound model and were proposed as promising
antimicrobial wound dressing with good biocompatibility to promote scald wound healing
[100].
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The use of cellulose/nanosilver sponge materials was strongly encouraged in case of serious
wound infection and in vivo tests confirmed accelerate infected wound healing and absorbing
capacity for wound exudate [101]. Other examples of composite scaffolds are biocomposite
films containing alginate and sago starch impregnated with silver nanoparticles [102], chitin/
nanosilver composite scaffolds and electrospun mats doped with nanosilver, zinc oxide, etc.,
as degradable and non-degradable polymers [103, 104]. For example, polymeric nanofilm-
containing silver nanoparticles exhibit antimicrobial activity at loadings and release rates of
silver lower than conventional dressings. When placed on a moist wound, the PVA dissolves
and the silver-loaded nanofilm results immobilized on the wound bed, thus allowing the
normal and complete wound closure by re-epithelialization [104]. A general overview of some
relevant techniques adopted to incorporate nanometals into hydrogel network for wound
dressing production is reported in Table 1.
Nanomaterial Description of the technique References
Zinc oxide (ZnO) Hydrogel/zinc oxide nanoparticles (nZnO) composite wound dressings
developed by freeze-dry method from the mixture of nZnO and alginate or
chitosan hydrogels.
[73–76]
Copper oxide
(CuO)
Cu2+ cross-linked alginate hydrogels by a two-step cross-linking technique. (i)
Preparation of solid alginate films through solvent-casting method from soft gels
of alginate solutions lightly cross-linked using a Cu2+ sulphate solution;
(ii) further cross-linking of the films in Cu2+ sulphate solution using a
dipping method.
[79]
Silver
nanoparticles
Silver nanoparticles incorporated in hydrogels network using microwave/electro-
spinning, gamma radiation, self-assembling. Composite sponges and films
obtained by freeze drying and solvent casting.
[89–91, 101, 102]
Table 1. Overview of some relevant techniques for production of nanometal-based antimicrobial wound dressings.
The widespread use of silver-based dressings in surgery is promising, inexpensive and well
tolerated. The placement of silver-nylon dressings over incision sites in colorectal, neurologi-
cal, spinal, cardiovascular and orthopaedic procedures at the time of primary closure has been
described by Abboud et al. as effective in reducing surgical site infection rates [105]. Commer-
cial dressings impregnated by immersion in solutions of AgNPs using different concentrations
of silver from 125 to 1000 ppm demonstrated anti-biofilm efficacy against Pseudomonas
aeruginosa [70]. Conventional cotton gauzes were modified by Sannino et al. through the
deposition of silver-based nanocoatings obtained by a patented photo-assisted deposition
process, which allows the silver treatment of natural and synthetic materials for different
applications [106–108]. Particularly, the technology adopted involves the preparation of a
silver-based solution, and then the deposition of the silver solution onto the surface of the
material through spray coating or dip coating and the following exposure of the wet material
to ultraviolet light, in order to induce the photo-chemical deposition of silver nanoparticles on
the surface of the product. Indeed, the synthesis and deposition of the silver nanoparticles
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occur simultaneously onto the surface of the material because the photo-reduction reaction
induced by UV irradiation determines the conversion from the silver precursor to metal silver
nanoparticles. The silver coatings deposited are characterized by a strong adhesion to the
substrate, good antimicrobial capability and biocompatibility and low silver release [109].
Cotton gauzes treated with low amounts of silver have demonstrated good antimicrobial
activity against different bacterial strains and fungi, and the good antibacterial properties were
further confirmed in simulated working conditions such as after incubation in artificial exudate
inoculated with bacteria [110]. Figure 1 reports the agar diffusion test performed on untreated
gauze and gauze treated with silver by adopting the technology described using Staphylococcus
aureus as tester microorganism.
Figure 1. Agar diffusion tests on untreated gauze and cotton gauze treated by photo-reduction technology.
Description of the product Application References
Polyester textile mesh impregnated with hydrocolloid
particles, vaseline and silver sulphate.
Low to moderate exuding acute and chronic
wound at risk of infection.
[112, 113]
Sodium carboxymethylcellulose hydrofibres combined
with ionic silver.
Acute and chronic wounds at risk of infection,
with moderate and abundant exudate.
[112, 113]
Flexible polyethylene cloth coated with nanocrystalline
Ag particles.
Infected ulcers, surgical wounds and burns. [87, 112]
Silver nylon cloth/activated charcoal. Most type of chronic wounds and infected
wounds and ulcers.
[112, 114]
Table 2. Examples of commercial silver-containing dressings.
Although the impregnating silver solution was prepared by using a percentage of silver lower
than 0.5 wt/v%, the antibacterial test clearly demonstrated that the presence of the silver
coating successfully inhibited the bacterial growth beneath and around the sample, thus
indicating a good potential of product as antibacterial wound dressing. Also flax substrates
have been treated with silver by adopting the same technology and the microbiological activity
was still confirmed after industrial washing, thus suggesting the excellent stability of the
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coating on the surface of the textile material [111, 112]. In order to provide flax substrates with
a moist environment and antibacterial capability at same time, Paladini et al. has developed a
wound dressing biomaterial based on silver-doped self-assembling di-phenylalanine hydro-
gels. These peptide-based hydrogels have some similarities to the extracellular matrix due to
their high hydration and nanofibrous architecture, which make them suitable for wound
dressing applications where the wound environment needs to be controlled to prevent
microbial invasion and to favour tissue regeneration [113]. Along with research efforts, in
recent years, many silver-based wound dressings have been marketed for medical problems
such as wide-body burns, sepsis in traumatic wounds and chronic diabetic ulcers [114, 115].
Some examples are collected in Table 2.
5. Conclusion and future perspectives
Nanotechnology is gaining huge impetus in the present century due to the drastic changes of
chemical, physical and optical properties of metals at nanoscale size [84]. The cutting-edge
combination of nanotechnology with medicine offers unprecedented opportunities to revolu-
tionize currently available macro-scale therapeutics. Nanoparticles-based delivery systems
can be highly beneficial to improve the therapeutic power of biological and synthetic mole-
cules [90]. Due to the knowledge of cellular and molecular processes underlying wound
healing, the new therapeutic approaches act directly on cellular and subcellular events during
the healing process [90].
In recent years, metal nanoparticles/polymer composites have created lot of attraction due to
their wide range of applications [41]. The interest in broad-spectrum antimicrobial agents is
particularly increasing for medicated wound dressings, in order to control colonization of
wounds by opportunistic pathogens. Medicated wound dressings have demonstrated efficacy
in vitro against planktonic microorganisms; however, in vivo bacteria are organized in biofilms,
which is more challenging to control and eradicate [116]. Silver nanoparticles, in particular,
have been identified as potent antimicrobial agent and are being evaluated in different medical
applications ranging from silver based dressings to silver coated medical devices [117]. Silver
in ionized form or nanoparticles exhibits excellent antimicrobial and antifungal properties and
efficacy in preventing biofilm formation by pathogenic bacteria. Silver-based wound dressings
are widely used in clinical practice and show promising results in healing of contaminated
wounds [118].
Despite its recognized importance, there have not been systemic studies that probe the
targeting efficiency of nanoparticles nor international standards on their toxicology and
biocompatibility [119]. Despite their promise, further studies are needed to elucidate the
pharmacokinetics of nanoparticles and potential for in vivo toxicity. However, to date, studies
have found limited toxicity without evidence of systemic absorption [120].
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